Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;64(1):44-50.
doi: 10.1111/ijd.17350. Epub 2024 Jul 4.

Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations

Affiliations
Review

Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations

Muna Shakhashiro et al. Int J Dermatol. 2025 Jan.

Abstract

Yao syndrome (YAOS) is a novel systemic autoinflammatory disease linked to the nucleotide-binding oligomerization domain (NOD2) gene. It is characterized by periodic fevers, gastrointestinal (GI) symptoms, arthritis, and dermatitis, among other symptoms. A sparse literature exists on this disease, and little is known about its dermatological manifestations. A review of available literature was performed to characterize the cutaneous manifestations of Yao syndrome. Cutaneous manifestations were documented in 85.7% of patients, with common characteristic descriptions of erythematous patches and plaques involving the face, trunk, abdomen, and extremities. Based on our review of treatment modalities employed for Yao syndrome, prednisone is an appropriate initial approach, with oral sulfasalazine and other disease-modifying antirheumatic drugs serving as appropriate secondary options. YAOS should be considered in the differential diagnosis of patients presenting with a dermatitic rash, especially in the context of concurrent articular symptoms, periodic fever, and GI symptoms.

Keywords: NOD2; Yao syndrome; autoinflammatory disease; cutaneous manifestations; narrative review.

PubMed Disclaimer

References

    1. Yao Q, Zhou L, Cusumano P, Bose N, Piliang M, Jayakar B, et al. A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis Res Ther. 2011;13(5):R148.
    1. Yao Q, Shen M, McDonald C, Lacbawan F, Moran R, Shen B. NOD2‐associated autoinflammatory disease: a large cohort study. Rheumatology. 2015;54(10):1904–1912.
    1. Rivera EG, Patnaik A, Salvemini J, Jain S, Lee K, Lozeau D, et al. SARS‐CoV‐2/COVID 19 and its relationship with NOD2 and ubiquitination. Clin Immunol. 2022;238:109027.
    1. Trueb B, Zhuang L, Keller I, Kockritz LV, Kuchen S, Dufour JF, et al. Coincidence of NOD2‐associated autoinflammatory disease (Yao Syndrome) and HCV infection with fatal consequences: interaction between genes and environment. J Clin Rheumatol. 2021;27(8S):S592–S594.
    1. Brailsford CJ, Khamdan F, Elston DM. Treatment of refractory Yao syndrome with canakinumab. JAAD Case Rep. 2022;29:37–40.

MeSH terms

LinkOut - more resources